XAIR

Beyond Air, Inc. is a clinical-stage medical device and pharmaceutical company developing innovative nitric oxide (NO) delivery systems for respiratory and other diseases. The company's lead product, LungFit, delivers precisely metered doses of nitric oxide for the treatment of conditions including persistent pulmonary hypertension of the newborn and bronchiolitis. Beyond Air is focused on leveraging the therapeutic benefits of nitric oxide to address unmet medical needs.